Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravitreal Injections of Melphalan for Retinoblastoma

NCT01558960 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT01558960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01558960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravitreal Injections of Melphalan for Retinoblastoma
Lead sponsor
Hadassah Medical Organization
Phase
Not applicable
Overall status
Terminated
Start date
March 31, 2012
Completion date
August 31, 2015
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retinoblastoma